Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **cell wall synthesis machinery in bacteria** comprises several dynamic multi-protein complexes responsible for the assembly and remodeling of the peptidoglycan layer, which is essential for maintaining cell shape, structural integrity, and viability. Key elements include the **elongasome** (responsible for cell elongation, involves actin-like MreB, RodA, and penicillin-binding protein 2) and the **divisome** (organizes cell division, involves tubulin-like FtsZ, FtsW, and penicillin-binding protein 3). Core activities include glycan strand polymerization (by SEDS family proteins such as RodA and FtsW), peptide cross-linking (by class A and B penicillin-binding proteins), and regulated insertion of new peptidoglycan at specific cellular sites. This machinery is a proven and widely exploited **antibiotic target**; inhibiting these processes leads to cell lysis. Its functional complexity and redundancy provide both vulnerabilities (for antibacterial therapies) and mechanisms by which bacteria evolve drug resistance. **Note:** The entry *cell wall synthesis machinery in bacteria* is not a single molecule or gene but rather a collection of interdependent protein complexes and enzymes. This is a level of specificity broader than a canonical single target (e.g., "penicillin-binding protein 2"), leading to the flagging of is_incorrect: true. For precise drug-target relations, individual enzymes (such as PBP2, MurA, or RodA) should be annotated separately.
Inhibition of transpeptidase activity (cross-linking; e.g., β-lactams); Inhibition of glycan polymerization (e.g., moenomycin); Inhibition of precursor biosynthesis (e.g., fosfomycin blocks MurA, D-cycloserine inhibits alanine racemase and D-Ala-D-Ala ligase, bacitracin blocks lipid carrier recycling); Disruption of peptidoglycan cross-linking (e.g., vancomycin binds D-Ala-D-Ala termini)
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell wall synthesis machinery (bacterial).